D-Ribose-1,2-13C2
Modify Date: 2024-01-10 16:46:14
D-Ribose-1,2-13C2 structure
|
Common Name | D-Ribose-1,2-13C2 | ||
|---|---|---|---|---|
| CAS Number | 209909-88-6 | Molecular Weight | 152.12 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C313C2H10O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of D-Ribose-1,2-13C2D-Ribose-1,2-13C2 is the 13C labled D-Ribose(mixture of isomers) (HY-W018772)[1]. D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[2]. |
| Name | d-[1,2-13c2]ribose |
|---|
| Description | D-Ribose-1,2-13C2 is the 13C labled D-Ribose(mixture of isomers) (HY-W018772)[1]. D-Ribose(mixture of isomers) is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose(mixture of isomers) is active in protein glycation, induces NF-κB inflammation in a RAGE-dependent manner[2]. |
|---|---|
| Related Catalog | |
| In Vitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 |
| References |
| Molecular Formula | C313C2H10O5 |
|---|---|
| Molecular Weight | 152.12 |
| Exact Mass | 152.06000 |
| PSA | 90.15000 |